Contingencies and commitments

Notes
CSR report

Contractual obligations and commitments

We have certain purchase commitments principally with CRO subcontractors and certain collaboration partners.

On 31 March 2021, we had outstanding obligations for purchase commitments, which become due as follows:

(thousands of €)

Total

Less than 1 year

1 – 3 years

3 – 5 years

More than 5 years

Purchase commitments

319,267

252,913

52,599

13,093

662

In addition to the table above, we have a contractual cost sharing obligation related to our collaboration agreement with Gilead for filgotinib. The contractual cost sharing commitment amounted to €482.8 million at 31 March 2021 for which we have direct purchase commitments of €23.5 million at 31 March 2021 reflected in the table above.

Contingent liabilities and assets

We refer to our Annual Report 2020 for a description of our contingent liabilities and assets.